Health
For more information concerning work and views related to Health, please contact our office.
More on Health
Congress is on track to approve legislation that would mark a significant advance in U.S. policy toward psychedelics.
Tucked into the National Defense Authorization Act of 2024 is a provision to fund clinical trials using psychedelic substances to treat active duty members of the military.
By Rick Perry, Marcus Luttrell, Morgan Luttrell & Dakota Meyer
As the opioid epidemic continues to grip our nation, claiming lives, destroying families, and burdening communities, it is imperative that we explore every viable solution. Among these potential solutions is a powerful, natural, non-addictive substance known as ibogaine. As voices that have served in political and military capacities, we unite in our appeal to the Kentucky Opioid Abatement Advisory Commission (KYOAAC): Allocate $42 million for ibogaine research.
More than twice as many U.S. service members may have been injured in recent attacks in Iraq and Syria than the Pentagon previously disclosed, U.S. defense officials said on Monday. At least 45 Americans are reporting minor injuries or potential traumatic brain injuries.
Experts and advocates—including a Department of Veterans Affairs (VA) official and a former director of the Centers for Disease Control and Prevention (CDC)—recently convened for a Harvard University panel to discuss efforts to expand veteran access to psychedelic-assisted therapy. Speakers broadly agreed that psychedelic substances like MDMA and psilocybin hold powerful potential to help treat PTSD and curb suicide rates in service members, but they cautioned against hasty, unsupervised use of psychedelics given the possibility for further harms.
The fentanyl crisis continues to rage across the United States. Families from Alaska to Maine have felt the impact of this crisis driven by a manufactured opioid shake them to their core. Unfortunately, this crisis has reached our service members. In the U.S. Army and Navy, our two largest branches, we’ve learned that fentanyl deaths are on the rise. As a veteran, I recognize firsthand that this is a dangerous threat to our national security and the Biden administration must be held accountable for its policies that have played a central role in the crisis.
WASHINGTON – Congressman Morgan Luttrell (R-TX) offered an amendment to the Department of Defense (DOD) Appropriations Act of 2024 that would provide funding for clinical trials on psychedelics as a modality to treat brain injuries sustained by servicemembers and veterans while serving our country. The amendment was adopted and passed in the House of Representatives last night with bipartisan support.
The House approved an amendment to the Department of Defense Appropriations bill Wednesday that would provide $15 million to the Defense Department to conduct medical clinical trials for veterans using psychedelics to treat traumatic brain injuries.
WASHINGTON – As a highly decorated Navy SEAL training commander’s career hangs in the balance, three Republican lawmakers are demanding answers about the integrity of the investigation that is sending him to a punishment hearing, The Post has exclusively learned.
WASHINGTON – Congressman Morgan Luttrell (R-TX) led a letter to United States Department of Health and Human Services (HHS) Secretary Xavier Becerra expressing concern over the lack of effort to address Traumatic Brain Injury (TBI) and advocating for HHS to establish a National Traumatic Brain Injury Task Force to transform the treatment and care of TBI patients.
WASHINGTON – Congressman Morgan Luttrell (R-TX), Chairman of the Veterans' Affairs Subcommittee on Disability Assistance and Memorial Affairs (DAMA), authored the Veterans’ Benefits Improvement Act (H.R. 1530), which the House of Representatives passed today with bipartisan support. The legislation now heads to the Senate for consideration.